Rifabutin Unknown Status Phase 1 Trials for Successfully Completed TB Treatment in the Past 2 to 6 Weeks of Enrollment / Children With Confirmed HIV Infection / Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose Treatment

IndicationsStatusPurposePhase
Unknown StatusTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT01259219Dosing, Safety and Pharmacokinetic Profile of Rifabutin in Children Receiving Concomitant Treatment With Kaletra